Featured News

Flexibility, creativity, and dedication to make better therapeutics are at the heart of what we do. Read more on recent updates and highlights around our contract drug manufacturing activities.

Approved Social Graphic - News (1)

BIOVECTRA partners on Canadian solution to establish a domestic supply chain for immunotherapies

February 26, 2024

BIOVECTRA is pleased to be part of a Canadian solution with our NGEN partners CCRM, Precision Nanosytems (Cytiva), Northern RNA, and OmniaBio to establish a Canadian supply chain network to accelerate and standardize lentiviral vector development from clinical to commercial manufacturing.  […]

Read More

  • Categories